HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ARROW: pralsetinib hits target across cancers.

AuthorsDavid Killock
JournalNature reviews. Clinical oncology (Nat Rev Clin Oncol) Vol. 19 Issue 10 Pg. 615 (10 2022) ISSN: 1759-4782 [Electronic] England
PMID35999290 (Publication Type: Journal Article, Comment)
Chemical References
  • Pyrazoles
  • Pyridines
  • Pyrimidines
  • pralsetinib
Topics
  • Humans
  • Neoplasms (drug therapy)
  • Pyrazoles
  • Pyridines
  • Pyrimidines

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: